2024
DOI: 10.1016/j.nefro.2024.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Evaluación de eventos clínicos y costes asociados a la adición de dapagliflozina al tratamiento de la enfermedad renal crónica: análisis de compensación de costes

Juan Francisco Navarro-González,
Alberto Ortiz,
Ana Cebrián Cuenca
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 22 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?